Results 151 to 160 of about 1,281,552 (342)
Cost-effectiveness analysis and its application for policy evaluation for medicine or public health [PDF]
In comparison to the policy for other field, the policy for medicine and public health is to consider the value of life or the value of the quality of life. Quality of life is very well known as a concept of QOL.
Tamie Sugawara, Yasushi Ohkusa
core +1 more source
Amyotrophic Lateral Sclerosis Prevalence Projection in 2040: A Less Rare Disease
ABSTRACT Objective To project ALS prevalence across multiple countries through 2040, accounting for both population aging and increased survival. Methods Data from the Piemonte and Valle d'Aosta ALS register (PARALS) was used to estimate the trends in incidence and prevalence from 2005 to 2019. Survival trends over this period were also assessed.
Rosario Vasta +18 more
wiley +1 more source
The cost effectiveness of a radiation therapy simulator: A model for the determination of need
Anatoly Dritschilo +4 more
openalex +1 more source
Cost Effectiveness of Alternative Subsidy Strategies for Soil Erosion Control [PDF]
William M. Park, D. Sawyer
openalex +1 more source
Objective We assessed whether shared decision‐making (SDM), and patient acceptability, feasibility, and overall satisfaction with a computerized patient decision aid (PtDA) for patients with systemic lupus erythematosus (SLE), differs by PtDA setting, modality, and the viewing experience.
Jasvinder A. Singh +3 more
wiley +1 more source
Validity and Cost-Effectiveness of the Gonozyme Test in the Diagnosis of Gonorrhea [PDF]
E. Thomas +6 more
openalex +1 more source
PROBABILISTIC COST EFFECTIVENESS IN AGRICULTURAL NONPOINT POLLUTION CONTROL [PDF]
Conceptual weaknesses in the use of costs of average abatement as a measure of the cost effectiveness of agricultural nonpoint pollution control are examined. A probabilistic alternative is developed.
McSweeny, William T., Shortle, James S.
core +1 more source
Objective This study aimed to evaluate the impact of a series of policies that mandated switching patients with inflammatory arthritis (IA) from an originator biologic to a biosimilar in British Columbia, Canada, on health care resource use and cost.
HaoHung Dang +4 more
wiley +1 more source
A Cost Effectiveness Model for Comparing Various Circulation Systems
Thomas K. Burgess
openalex +2 more sources
Cost-effectiveness of the stream-gaging program in the Hawaii District [PDF]
Iwao Matsuoka, R. Lee, Wilbert O. Thomas
openalex +1 more source

